Bringing Innovative Medical Technologies to the GCC
Nexopro helps specialized medical-device companies navigate regulatory requirements, establish clinical adoption, and build sustainable commercial presence across Gulf healthcare markets.
Specialized Medical Technologies
We focus on innovative technologies addressing complex clinical needs and specialist applications.
GCC Expertise
Regulatory knowledge, hospital access, and market development experience across Gulf healthcare systems.
Manufacturer Partnerships
We support partners from market entry through regulatory, clinical, tender, and commercial execution.
Specialized Medical Technologies
A focused portfolio of innovative technologies selected for meaningful clinical impact and specialist healthcare applications.
FlexDex
by FlexDex Surgical
Articulated needle driver designed to enhance precision in minimally invasive surgery.
NeuRx DPS
by Synapse Biomedical
Diaphragm pacing technology for Diaphragm Dysfunction in patients with spinal cord injury or Neuromuscular Disease.
TransAeris
by Synapse Biomedical
Technology designed to prevent and treat Ventilator Induced Diaphragm Dysfunction in ICU.
Your GCC Commercialization Partner
We support innovative medical-device companies across the full market-entry journey.
From regulatory access and clinical engagement to tenders, hospital adoption, and commercial growth.
Regulatory & Market Access
Navigate local registration pathways, documentation requirements, and market-entry processes.
Clinical Engagement
Build relationships with specialists, KOLs, and clinical stakeholders who influence adoption.
Commercial Development
Translate market access into sustainable sales execution and regional expansion.
Hospital and Tender Access
Support institutional engagement, procurement pathways, and tender participation.
Built for The GCC Healthcare Market
Nexopro combines regional market knowledge, specialist product focus, and direct healthcare engagement across Gulf markets.
Since 2017
Specialist medical-device distribution and market development.
6 GCC Markets
Supporting opportunities across the UAE, KSA, Kuwait, Qatar, Bahrain, and Oman.
Specialist Portfolio
Differentiated technologies for complex clinical applications.
End-to-End Support
Regulatory, clinical, tender, and commercial execution.
Clinical News & Updates
Clinical insights, medical-technology developments, and healthcare updates relevant to our specialist portfolio and GCC markets.
-
NeuRx DPS Receives a new FDA approval
NeuRx DPS, the world leading diaphragm pacing device, helping hundreds of pateints move away from mechanical ventilation, has […]
-
Diaphragm Pacing in Ventilation Management for High Spinal Cord Injury
The American College of Surgeons have issued their guidelines for Spine Surgery in March 2022, The guidelines recommends […]
-
TransAeris deemed a Breakthrough Device by FDA
Using the same technology of diaphragm pacing as its predecessor, and the flagship of Synapse Biomedical Inc®. NeuRx […]
News post coming soon.
News post coming soon.
News post coming soon.